Intrauterine Devices

Intrauterine Devices

Global Intrauterine Devices Market to Reach US$4.9 Billion by 2030

The global market for Intrauterine Devices estimated at US$3.8 Billion in the year 2023, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 3.8% over the analysis period 2023-2030. Hormonal Progestogen-Releasing IUD, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$3.4 Billion by the end of the analysis period. Growth in the Nonhormonal Copper-Containing IUD segment is estimated at 4.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.0 Billion While China is Forecast to Grow at 3.6% CAGR

The Intrauterine Devices market in the U.S. is estimated at US$1.0 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$776.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Intrauterine Devices Market - Key Trends & Drivers Summarized

What Are Intrauterine Devices and Why Are They a Popular Choice for Long-Term Contraception?

Intrauterine devices (IUDs) are small, T-shaped contraceptive devices that are inserted into the uterus to prevent pregnancy. They are a popular choice for long-term contraception due to their high effectiveness, convenience, and reversibility. IUDs can be hormonal or non-hormonal, with the former releasing small amounts of progestin to prevent ovulation and the latter, typically made of copper, creating an environment that is toxic to sperm. IUDs provide protection against pregnancy for several years, making them an attractive option for women seeking long-term, hassle-free contraception. Their ability to be removed at any time, allowing for a quick return to fertility, further enhances their appeal. As awareness of the benefits of IUDs increases, they are becoming a preferred contraceptive method among women worldwide.

How Are Technological Advancements Shaping the Intrauterine Devices Market?

Technological advancements are significantly shaping the intrauterine devices market, particularly through innovations in device design, materials, and safety features. Modern IUDs are being designed to offer improved comfort and ease of insertion, with some models featuring smaller sizes and flexible materials to reduce discomfort during placement. Advances in hormonal IUDs have led to the development of devices that release lower doses of hormones over longer periods, reducing the risk of side effects while maintaining efficacy. Additionally, the introduction of IUDs with enhanced safety profiles, such as devices that minimize the risk of perforation and expulsion, is contributing to increased adoption. These innovations are making IUDs more accessible and appealing to a broader range of women, driving growth in the market.

Why Is There an Increasing Demand for Intrauterine Devices in Contraceptive Care?

The demand for intrauterine devices is increasing in contraceptive care due to the growing emphasis on long-term, reliable, and low-maintenance birth control options. As women seek alternatives to daily oral contraceptives and short-term methods like injections or patches, IUDs offer a highly effective solution that requires little ongoing maintenance. The rising awareness of the long-term health benefits of IUDs, such as their non-interference with breastfeeding and their potential to reduce the risk of certain cancers, is also driving demand. Additionally, the global trend towards delaying childbirth and the increasing availability of family planning services are contributing to the growing popularity of IUDs. As more women prioritize effective, convenient, and reversible contraception, the demand for IUDs is expected to continue to rise.

What Factors Are Driving the Growth in the Intrauterine Devices Market?

The growth in the intrauterine devices market is driven by several factors related to technological advancements, changing consumer preferences, and the increasing availability of contraceptive options. One of the primary drivers is the advancement in IUD design and materials, which has improved the comfort, safety, and efficacy of these devices, making them more attractive to a wider range of women. The growing preference for long-term, low-maintenance contraception is also fueling demand, as IUDs offer a reliable alternative to daily or short-term methods. The increasing availability of family planning services and the global push for reproductive health and rights are further contributing to market growth, as more women gain access to contraceptive options. Additionally, the rising awareness of the health benefits of IUDs, such as their potential to reduce the risk of certain cancers and their suitability for a wide range of women, is driving adoption. As these trends continue to evolve, the intrauterine devices market is expected to experience sustained growth, driven by the need for effective, safe, and convenient contraceptive solutions.

Select Competitors (Total 44 Featured) -

• Allergan PLC
• ANI Pharmaceuticals, Inc.
• Bayer AG
• Besins Healthcare (Monaco)
• CooperSurgical, Inc.
• Eurogine, S.L
• HLL Lifecare Ltd.
• HRA Pharma
• OCON Medical Ltd.
• Pregna International Ltd.
• SMB Corporation
• Teva Pharmaceutical Industries Ltd.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.